Numbness and Tingling in Hands and Feet: Which Nutrients Actually Have Evidence

Numbness and tingling in hands and feet is the kind of symptom you notice long before you understand it. Your fingers buzz. Your toes feel asleep. It comes and goes, and you have started wondering whether you are low in something. This page grades the nutrients one by one: strongest evidence, mixed, weak or unproven, and where the research runs out. One thing first.

The Short Answer: What Deficiency Causes Numbness and Tingling in Hands and Feet?

Vitamin B12 is the nutrient most often linked to tingling in hands and feet. It is the deficiency doctors look for first, and the one with the deepest research behind it. Vitamin B1 (thiamine) comes next. Either shortfall can show up as pins and needles, usually starting in the feet.

Here is the honest caveat. Most people with tingling in their hands and feet do not have a vitamin deficiency at all. The usual drivers are things a capsule cannot fix: raised blood sugar, pressure on a nerve, a medicine effect, or a problem in the neck or back. See a doctor first.

See a Doctor First: When Tingling Needs Medical Attention

New or changing numbness is a symptom a doctor should assess, not a puzzle to solve with a supplement bottle.

Get emergency care right away if...

Call emergency services or go to an emergency department if tingling comes with any of these:

• Sudden numbness or weakness on one side
• Trouble speaking or understanding
• Sudden vision change
• Sudden severe imbalance or trouble walking
• Loss of bladder or bowel control
• Numbness after a head, neck, or back injury
• Numbness spreading quickly
• Numbness in the saddle area
• Numbness with confusion, fainting, or breathing difficulty

Some of these are how a stroke or a spinal cord problem shows up.

Book an appointment soon if...

• The tingling keeps returning, or is getting worse
• It is in both hands and both feet at once
• It comes with neck or back pain
• It comes with dizziness, muscle twitching, or other unexplained changes
• You take a medicine that can affect nerves or nutrient absorption
• You have had stomach or bowel surgery

Why this section comes before the nutrient list

A nutritional cause is often correctable once identified, but it is a diagnosis, and diagnosis is a doctor's job. [1]

What Tingling in Hands and Feet Actually Means

"Pins and needles", explained in plain language

When a nerve is irritated, compressed, or short of the nutrients it needs, its signals get noisy. [1] You feel that noise as tingling.

Why nerves notice a nutrient shortfall early

Nerves are long cells, and some run the whole distance from your spine to your toes. A shortfall the rest of your body tolerates can show up in the longest nerves first, which is why tingling often starts in the feet. [1]

Nerves also need B vitamins to maintain their myelin sheath, and when that supply runs low, sensation is among the earliest things to change. [2]

Hands only, feet only, or both: what the pattern tells you

• Feet first, then hands, both sides. The classic length-dependent pattern, fitting nutrient and blood sugar related causes. [1]
• One hand only, or a few fingers. This points to pressure on a nerve, a mechanical problem rather than a nutritional one.
• Both hands and both feet at once, suddenly. Needs prompt assessment.
• Numbness moving upward over hours or days. Needs urgent assessment. [1]

Who Is Actually at Risk of a Nutrient Shortfall?

Most people reading this are not deficient. But some groups run low more often than others.

Medicines that can lower B12 and other nutrients

• Metformin, used for blood sugar, is the most studied. In a US database of 14,808 adults with type 2 diabetes, people who had taken it four years or more were 67% more likely to be low in B12 than people who never took it. [3]
• Long-term acid suppressants are linked to lower B12 absorption.
• Isoniazid, a tuberculosis medicine, can affect B6 handling. [4]

Now the honest part. That metformin signal is not consistent. A Danish study of 3,958 adults with diabetes, using stricter criteria, found deficiency in 2.3% of metformin users versus 1.3% of non-users, with confidence intervals crossing the line of no difference. [5] A 2025 review found guidelines still vague or silent. [6] If you take a medicine that can affect nutrient levels, ask your prescriber about testing.

Digestive surgery and absorption problems

B12 needs stomach acid and a protein called intrinsic factor to be absorbed, and surgery that bypasses part of the stomach or bowel can reduce that. [1]

Diet patterns: plant-based eating and alcohol

B12 occurs naturally in animal foods, so a strict plant-based diet without fortified foods or a supplement is a genuine risk factor. In a small study of 38 young adults who had eaten vegetarian or vegan for three years, 26% had deficient or marginal B12 status. [2] Heavy alcohol use affects thiamine (B1) status. [1]

Age

In a study of 427 healthy people in Iraq, B12 deficiency was 38.7% overall and 42.6% in the elderly. [7] One region's number, not a global rate, but the age trend is consistent.

The mineral trap: too much zinc can deplete copper

Zinc triggers a gut protein that binds copper and reduces how much you absorb. Over time a high zinc intake can push copper low, and low copper can produce numbness, balance problems, and falls. [8]

A case report describes a 70-year-old woman who developed six months of progressive numbness and unsteady walking after years on a zinc-containing eye-health supplement. Her copper was undetectable, and she recovered after the zinc was stopped and copper was replaced. [8] In a pharmacovigilance analysis of 2,646 adults on zinc, copper deficiency was reported in 3.8%. [9] If you take zinc daily and have new numbness, get your copper checked.

The Nutrients With the Strongest Evidence

Much of this research was done in people with raised blood sugar, because that is the group most studied for nerve symptoms. We report what those trials found about nerve comfort and symptom scores, not about any condition. This guide to blood sugar support supplements is a sensible companion read.

Vitamin B12: the best-supported link

Evidence strength: strongest. B12 has the clearest link to tingling, and it is what doctors test first.

• In a hospital study of 139 people with raised blood sugar and nerve symptoms in Pakistan, 48.2% were B12 deficient, rising to 72.8% beyond five years of raised blood sugar. [10] One centre's population, not a global figure.
• In a trial of 40 people receiving a nerve-toxic medical treatment, oral cyanocobalamin 500 micrograms twice daily reduced the incidence of nerve symptoms versus placebo. [11] Very small, and that context does not apply to most readers.
• B12 is needed for normal nerve function and for the normal maintenance of the myelin sheath. [2]

Cyanocobalamin and methylcobalamin are not identical. This comparison of vitamin B12 forms covers the differences, and this overview of B12 deficiency symptoms covers what else shows up alongside tingling.

Agape's B12 range includes DaVinci Labs, Chewable B12-MC, a methylcobalamin option.

Vitamin B1 and benfotiamine: a lipid-soluble form with real trials

Evidence strength: mixed, and thinner than the marketing suggests. Thiamine (B1) is needed for normal nerve function. Benfotiamine is a lipid-soluble form built to raise tissue levels more effectively.

• In BENDIP, 165 people were randomised to benfotiamine 600 mg/day, 300 mg/day, or placebo for 6 weeks, with 133 analysed. The primary symptom score improved per-protocol (p=0.033) but missed significance intention-to-treat (p=0.055), and the secondary total symptom score showed no significant difference at all. [12]
• In a thiamine-deficient region, 41 people with weakness were given thiamine. 16 of the 41 did not respond at all, while responders improved within 24 hours. [13]

And here is the ceiling, from the researchers themselves. A 2026 critical review concluded benfotiamine evidence "remains limited to short-duration, symptom-based studies," and that outside of documented thiamine deficiency, routine use cannot be recommended on current evidence. [14]

Agape stocks lipid-soluble thiamine forms such as Ecological Formulas, Allithiamine 50 mg.

Alpha-lipoic acid: the most studied, and the most contested

Evidence strength: contested. More trials exist for alpha-lipoic acid (ALA) than anything else here. They disagree, and the highest-quality review is negative.

• Cochrane 2024. Three trials, 816 participants, high risk of bias from dropouts. ALA "probably has little or no effect on neuropathy symptoms" at six months. [15]
• NATHAN 1. 460 people, oral ALA 600 mg daily for four years. The primary endpoint was not met (p=0.105), though some secondary measures improved. [16] Serious adverse events were reported more often on alpha-lipoic acid (38.1%) than on placebo (28.0%) over the four years, and those counts cover all serious events, not only nerve related ones. [16]
• Two meta-analyses disagree. A 2023 review found no significant change on any scale. [17] A 2012 review found a large symptom-score reduction, but from an intravenous route. [18]

The most-studied nutrient here is the one where the best evidence is negative.

The comparison table

Vitamin B6: The Nutrient That Cuts Both Ways

B6 is the one nutrient here that can plausibly work in both directions. Too much B6 produces the exact symptom you are searching about.

Too little B6 and normal nerve function

B6 is needed for normal nerve function, and a genuine deficiency is associated with nerve-related symptoms. On a varied diet it is uncommon. [19]

Too much B6 and the very symptom you are trying to fix

This is the part almost nobody tells you.

The Netherlands lowered the maximum daily dose of vitamin B6 in supplements to 21 mg/day, effective October 2018, after reports of nerve-related symptoms linked to B6 were reviewed. After the cap took effect, new reports fell. [19] A clinical review in Australian general practice raises the same concern. [20]

B6 is also sometimes used alongside isoniazid to protect against nerve effects. In one case report, a patient given pyridoxine 150 mg daily deteriorated, and improved only after the pyridoxine was withdrawn. [4]

What the dose cap means for the bottle in your cupboard

1. Read the amount per serving on your B6 bottle and compare it to the 21 mg/day figure regulators settled on. [19]
2. If you take a B-complex, check the B6 number. It is often the highest in the blend.
3. If you have tingling and take high-dose B6, raise it with your doctor.

B6 is also old news as a remedy for hand and wrist symptoms, and a 2004 review of that research found few studies used proper diagnostic testing. [21] A 2013 trial that did show improvement used 120 mg/day, roughly six times the regulatory ceiling. [22]

The Nutrients With Weaker or Unproven Evidence

Four nutrients come up constantly in tingling conversations. Here is where each one actually stands.

Vitamin D: a strong association and a small trial base

Evidence strength: weak to moderate. A meta-analysis of 33 studies and 17,369 people found that people with nerve symptoms had significantly lower vitamin D levels, and that supplementation reduced pain severity. [23] Then look at the structure. The headline association came from 12 observational studies, which cannot show cause, and the supplementation finding came from 7 small studies totalling 437 people. [23] A separate meta-analysis of randomised trials alone pooled just 4 trials and 320 people. [24] Not worth assuming it explains your tingling.

Folate: promising numbers from thin evidence

Evidence strength: weak. Folate works alongside B12 in methylation. A 2025 systematic review reported pain reductions and improvement on symptom scales, but it is a narrative synthesis with no pooled effect estimate, so its striking figures do not support confident conclusions. [25]

Folate is worth checking if your doctor is already checking B12. Methylation also affects how your body handles these vitamins, and this guide to MTHFR and methylation explains that side of the picture.

Magnesium: interesting mechanism, no human trial evidence

Evidence strength: unproven for this symptom. Magnesium acts on NMDA receptors and on neuroinflammation, both of which relate to how nerves signal. A 2026 narrative review describes that biology clearly and then says the quiet part: "direct causal clinical evidence remains limited." [26]

A targeted search found no randomised human trial of oral magnesium for tingling or numbness. What exists is mechanistic review, animal work, and magnesium used in clinical procedures as an anaesthetic adjunct. We found no human trial evidence that oral magnesium reduces tingling. This guide to types of magnesium supplements covers the forms available.

Agape's magnesium range includes Integrative Therapeutics, Magnesium Glycinate Plus.

Omega-3: a null result worth knowing about

Evidence strength: null in humans. Cochrane 2025 reviewed randomised trials lasting 180 days or more, found only two completed trials with 87 participants in total, and concluded there "may be little to no benefit" of oral omega-3 for nerve symptoms or quality of life. [27] A mouse study points the other way, [28] but when animals and humans disagree, the human data wins.

Where the Evidence Runs Out

Most pages about this topic cover the causes and stop there. One 2026 review notes that despite ongoing work, no curative therapy exists. [29]

Nobody has shown structural nerve repair

A 2026 critical review put it plainly: no study has demonstrated structural nerve regeneration or a definitive disease-modifying effect. [14] The trials measure symptom scores, comfort, and function. They do not show that a nutrient rebuilds a nerve. What nutrients legitimately do is support normal nerve function.

Symptom scores move, nerve tests often do not

This pattern repeats across the literature.

• Benfotiamine improved the symptom score while the tuning fork test did not change. [30]
• NATHAN 1 missed its primary endpoint, which included nerve conduction measures, while some secondary impairment measures improved. [16]
• Cochrane 2024 found little or no effect on symptoms and only low-certainty evidence on impairment measures. [15]

People often report feeling better while the objective nerve measurements stay the same. A claim of measurable nerve improvement therefore needs objective evidence, and that is largely missing.

The route matters: intravenous results do not transfer to a capsule

The strongest positive alpha-lipoic acid result came from intravenous administration at 600 mg/day over three weeks. [18] A capsule is absorbed differently and reaches different concentrations over time.

Small trials, high dropout, and why the strongest reviews disagree

The B12 prevention trial had 40 participants. [11] The benfotiamine pilot had 40. [30] The omega-3 Cochrane review had 87 across two trials. [27] The ALA prevention trial enrolled 243 people and only 70 finished. [31]

Small trials with heavy dropout produce unstable results, which is why two meta-analyses of the same nutrient reach opposite conclusions. [18] [17]

How Long Does It Take to Feel Better?

Almost nobody answers the timing question. Here is what the trials show.

If the cause is a genuine deficiency

In the thiamine study, clinical improvement appeared within 24 hours in those who responded. [13] B12 repletion tends to be slower and is not guaranteed.

Why recovery is not guaranteed

In the thiamine study, 16 of 41 people did not respond at all. [13] ALA probably has little or no effect. [15] Omega-3 probably has little or no benefit. [27]

Do not measure success by whether a bottle "worked." Measure it by whether a test showed a deficiency, whether it was corrected, and what your doctor observes over time. And one more time, because this is where self-managing is most tempting: if your tingling is new, worsening, one-sided, or comes with any of the emergency signs listed at the top of this page, see a doctor.

What to Ask Your Doctor

On testing: Would you check B12 and methylmalonic acid, plus folate, vitamin D, copper, and HbA1c?

On medicines: I take a medicine that can affect nutrient levels. Should we test for that reason?

On history: Does my surgery history change my absorption? Could my zinc supplement be relevant here?

Agape's nutritional consultation is there for a longer conversation than a short appointment allows.

If your doctor has identified a shortfall, or you and your clinician have decided to cover a nutrient gap, these are the products Agape stocks that fit the evidence set out above. The grading on this page has not changed to suit them.

What We Recommend

References

Titles below carry the clinical wording of the original studies. They name the research we used, not a claim about any product or condition.

1. Staff NP, Windebank AJ. Peripheral neuropathy due to vitamin deficiency, toxins, and medications. Continuum (Minneapolis, Minn.), 2014. https://pubmed.ncbi.nlm.nih.gov/25299283/
2. Arnold T, Johnston CS. An examination of relationships between vitamin B12 status and functional measures of peripheral neuropathy in young adult vegetarians. Frontiers in Nutrition, 2023. https://pubmed.ncbi.nlm.nih.gov/38174111/
3. Sepassi A, Wang J, Yankowski S, Enkoji A, Okenwa M, Morello CM, Hurley-Kim K. Associations between long-term metformin use, the risk of vitamin B12 deficiency, and neuropathy: An All of Us research Program study. Diabetes Research and Clinical Practice, 2025. https://pubmed.ncbi.nlm.nih.gov/40850508/
4. Nisar M, Watkin SW, Bucknall RC, Agnew RA. Exacerbation of isoniazid induced peripheral neuropathy by pyridoxine. Thorax, 1990. https://pubmed.ncbi.nlm.nih.gov/2166360/
5. Laugesen K, Abildgaard AM, Hoffmann-Lucke E, Madsen LR, Parkner T, Knudsen ST. Metformin and Vitamin B12 Deficiency: A Prevalence Study. Endocrine Practice, 2026. https://pubmed.ncbi.nlm.nih.gov/42567282/
6. Alvarez M, Prieto AE, Portilla N, Moya D, Rincon O, Guzman I. Metformin-induced vitamin B12 deficiency: An underdiagnosed cause of diabetic neuropathy. World Journal of Diabetes, 2025. https://pubmed.ncbi.nlm.nih.gov/40697600/
7. Shwan AOA, Najmuldeen HH, Abdalrahman NA, Hamafaraj HJ, Alghofaili F. Prevalence of Vitamin B12 Deficiency and Its Association With Age and Gender in a Healthy Population From Sulaymaniyah City, Iraq. FASEB Journal, 2025. https://pubmed.ncbi.nlm.nih.gov/41196058/
8. Goodrich Z, Schneider J. Zinc-associated Copper Deficiency Myelopathy: A Case Report. Clinical Neuropharmacology, 2026. https://pubmed.ncbi.nlm.nih.gov/42757636/
9. Hiyama Y, Yamada T, Tomota E, Tomita T, Furukawa C, Nakamura T, Imai H, Nagao A, Sato M, Asada M, Goda M, Ishizawa K, Matsuo H. Characterizing clinical patterns and associated factors of zinc-induced copper deficiency: Insights from large-scale pharmacovigilance databases. Clinical Nutrition ESPEN, 2026. https://pubmed.ncbi.nlm.nih.gov/42217623/
10. Hayat T, Waqar R, Farsi S, Ali S, Asim M, Farooq U. Vitamin B12 Deficiency in Patients With Diabetic Peripheral Neuropathy: A Hospital-Based Cross-Sectional Study. Cureus, 2025. https://pubmed.ncbi.nlm.nih.gov/40777713/
11. Insin P, Chaiwongsa T, Prueksaritanond N. Oral Vitamin B12 versus Placebo for the Prevention of Chemotherapy-Induced Peripheral Neuropathy in Gynecological Cancer Patients: A Randomized, Double-Blind, Placebo-Controlled Trial. Asian Pacific Journal of Cancer Prevention, 2026. https://pubmed.ncbi.nlm.nih.gov/42169581/
12. Stracke H, Gaus W, Achenbach U, Federlin K, Bretzel RG. Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study. Experimental and Clinical Endocrinology and Diabetes, 2008. https://pubmed.ncbi.nlm.nih.gov/18473286/
13. Nisar S, Yousuf Wani I, Altaf U, Muzaffer U, Kareem O, Tanvir M, Ganie MA. Thiamine deficiency-related neuropathy: A reversible entity from an endemic area. European Journal of Neurology, 2024. https://pubmed.ncbi.nlm.nih.gov/38018774/
14. Ciubotaru A, Grosu C, Alexa D, Cucu LE, Schreiner TG, Bistriceanu CE, Mastaleru A, Azoicai D, Vamanu A, Patrascu A, Cuciureanu DI, Ignat EB. Alpha-Lipoic Acid and Benfotiamine in Diabetic Peripheral Neuropathy: A Critical Review of Mechanistic Rationale and Clinical Evidence Within a Nutritional Therapeutic Framework. Nutrients, 2026. https://pubmed.ncbi.nlm.nih.gov/42196997/
15. Baicus C, Purcarea A, von Elm E, Delcea C, Furtunescu FL. Alpha-lipoic acid for diabetic peripheral neuropathy. Cochrane Database of Systematic Reviews, 2024. https://pubmed.ncbi.nlm.nih.gov/38205823/
16. Ziegler D, Low PA, Litchy WJ, Boulton AJ, Vinik AI, Freeman R, Samigullin R, Tritschler H, Munzel U, Maus J, Schutte K, Dyck PJ. Efficacy and safety of antioxidant treatment with alpha-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care, 2011. https://pubmed.ncbi.nlm.nih.gov/21775755/
17. Orellana-Donoso M, Lopez-Chaparro M, Barahona-Vasquez M, Santana-Machuca A, Bruna-Mejias A, Nova-Baeza P, Valenzuela-Fuenzalida JJ. Effectiveness of alpha-lipoic acid in patients with neuropathic pain associated with type I and type II diabetes mellitus: A systematic review and meta-analysis. Medicine, 2023. https://pubmed.ncbi.nlm.nih.gov/37933068/
18. Mijnhout GS, Kollen BJ, Alkhalaf A, Kleefstra N, Bilo HJ. Alpha lipoic acid for symptomatic peripheral neuropathy in patients with diabetes: a meta-analysis of randomized controlled trials. International Journal of Endocrinology, 2012. https://pubmed.ncbi.nlm.nih.gov/22331979/
19. van Hunsel F, Scholl J, Vrolijk M, Ekhart C. Impact of Regulatory Action on Dose Maximalization for Vitamin B6 Dietary Supplements on the Reporting Pattern for Neuropathy. Pharmacoepidemiology and Drug Safety, 2025. https://pubmed.ncbi.nlm.nih.gov/39888171/
20. Sherley M. Pyridoxine toxicity from over-the-counter supplements. Australian Journal of General Practice, 2025. https://pubmed.ncbi.nlm.nih.gov/40754968/
21. Aufiero E, Stitik TP, Foye PM, Chen B. Pyridoxine hydrochloride treatment of carpal tunnel syndrome: a review. Nutrition Reviews, 2004. https://pubmed.ncbi.nlm.nih.gov/15098856/
22. Talebi M, Andalib S, Bakhti S, Ayromlou H, Aghili A, Talebi A. Effect of vitamin B6 on clinical symptoms and electrodiagnostic results of patients with carpal tunnel syndrome. Advanced Pharmaceutical Bulletin, 2013. https://pubmed.ncbi.nlm.nih.gov/24312849/
23. Alrabadi B, Matar HI, Bandak N, Alghzawi Y, Alshakhshir AE, Alrabadi F, Alkayed HA. Deficient vitamin D levels exacerbate diabetic peripheral neuropathy, and supplementation alleviates neuropathic pain. Nutritional Neuroscience, 2026. https://pubmed.ncbi.nlm.nih.gov/42776121/
24. Gilbody A, Gilbody J. Vitamin D for Painful Diabetic Neuropathy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Endocrinology, Diabetes and Metabolism, 2025. https://pubmed.ncbi.nlm.nih.gov/41139799/
25. Alves Maues AC, Moren Abat MG, Benlloch M, Mariscal G. Folate Supplementation for Peripheral Neuropathy: A Systematic Review. Nutrients, 2025. https://pubmed.ncbi.nlm.nih.gov/41156551/
26. Yoon Y, Park R, Shim J, Park J, Hwang J, Kim J, Lam KHS, Suryadi T, Suhaimi A. Magnesium at the Neurovascular Interface: A Narrative Review of Atherosclerosis, Peripheral Arterial Disease, and Neuropathic Pain. Nutrients, 2026. https://pubmed.ncbi.nlm.nih.gov/42280320/
27. Britten-Jones AC, Linstrom TA, Makrai E, Singh S, Busija L, MacIsaac RJ, Roberts LJ, Downie LE. Omega-3 fatty acid supplementation for distal symmetrical peripheral neuropathy in adults with diabetes mellitus. Cochrane Database of Systematic Reviews, 2025. https://pubmed.ncbi.nlm.nih.gov/40990181/
28. Melato J, Goldoni FC, Benvenutti L, et al. Omega-3-Enriched Fish oil reduces the chemotherapy-induced peripheral neuropathy in mice. Neuropharmacology, 2025. https://pubmed.ncbi.nlm.nih.gov/40015508/
29. Kurz FT, Jende JM, Salomir R, Lovblad KO, Lascano A, Gariani K. Diabetic Peripheral Neuropathy: Current Epidemiology, Diagnostic Advances, Biomarkers, and Management Strategies. Journal of Diabetes Research, 2026. https://pubmed.ncbi.nlm.nih.gov/42015589/
30. Haupt E, Ledermann H, Kopcke W. Benfotiamine in the treatment of diabetic polyneuropathy: a three-week randomized, controlled pilot study (BEDIP study). International Journal of Clinical Pharmacology and Therapeutics, 2005. https://pubmed.ncbi.nlm.nih.gov/15726875/
31. Guo Y, Jones D, Palmer JL, Forman A, Dakhil SR, Velasco MR, Weiss M, Gilman P, Mills GM, Noga SJ, Eng C, Overman MJ, Fisch MJ. Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial. Supportive Care in Cancer, 2014. https://pubmed.ncbi.nlm.nih.gov/24362907/

Frequently Asked Questions